Skip to main content
Fanli Digital Technology Co., Ltd logo

Fanli Digital Technology Co., Ltd — Investor Relations & Filings

Ticker · 600228 ISIN · CNE000000Y78 Shanghai Stock Exchange Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 2,248 across all filing types
Latest filing 2020-09-17 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600228

About Fanli Digital Technology Co., Ltd

https://corp.fanli.com/

Fanli Digital Technology Co., Ltd. provides e-commerce integration and digital marketing services. The company operates a comprehensive platform that connects consumers with various online retail ecosystems through value-added services such as cash-back rewards, discount coupons, and promotional insights. Its core business model focuses on performance-based marketing, utilizing data-driven strategies to facilitate sales conversions for brand partners. Key offerings include brand promotion, user loyalty management, and targeted advertising solutions. By integrating diverse shopping channels into a single interface, the company optimizes the consumer purchasing journey and provides brands with scalable traffic acquisition tools. The platform serves as a strategic intermediary, leveraging user behavioral data to enhance marketing efficiency and provide measurable returns for merchants while delivering cost savings to a broad user base.

Recent filings

Filing Released Lang Actions
上海享锐企业管理咨询事务所（有限合伙）等14家交易对手方关于所提供信息真实、准确和完整的承诺函
Regulatory Filings Classification · 95% confidence The document is a series of commitment letters regarding the truthfulness, accuracy, and completeness of information provided in relation to a major asset swap, issuance of shares, and cash payment transaction. It involves a change in controlling shareholders and actual controllers of the listed company. The document contains multiple signed commitment letters from various parties involved in the transaction. There are no financial statements, earnings data, or detailed financial analysis present. The document is not a report of financial results, audit, or management discussion. Instead, it is a formal declaration and commitment related to a transaction, ensuring compliance with regulatory requirements and legal responsibilities. This type of document is best classified as a Regulatory Filing (RNS) because it is a compliance-related announcement that does not fit into other specific categories such as M&A filings or capital updates, as it is a commitment letter rather than the transaction announcement itself or a proxy statement. The document length is substantial, but it is repetitive commitment letters rather than a full report or presentation. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2020-09-17 Chinese
及其董事、监事、高级管理人员关于所提供信息真实、准确和完整的承诺函
Regulatory Filings Classification · 95% confidence The document is a commitment letter regarding the truthfulness, accuracy, and completeness of information provided for a major asset swap and share issuance transaction. It includes legal commitments and signatures from company directors and senior management. The document does not contain financial statements or detailed financial data but is a formal attestation related to a transaction. It is not a full report, earnings release, or regulatory filing of financial results. It is also not a proxy solicitation or voting result announcement. Given the nature of the document as a legal commitment letter related to a transaction, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2020-09-17 Chinese
上海方达律师事务所关于江西昌九生物化工股份有限公司重大资产置换、发行股份及支付现金购买资产并募集配套资金暨关联交易之法律意见书
M&A Activity Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding a major asset swap, issuance of shares, cash purchase of assets, and related party transactions involving Jiangxi Changjiu Bio-chemical Co., Ltd. It includes detailed legal due diligence, references to Chinese securities laws, and various agreements and reports related to the transaction. The document is not a financial report, earnings release, or regulatory filing per se, but a legal opinion supporting a major corporate transaction. This type of document is best classified under M&A Activity (TAR) as it relates to merger and acquisition transaction documentation and legal opinions.
2020-09-17 Chinese
重大资产置换、发行股份及支付现金购买资产并募集配套资金暨关联交易报告书（草案）摘要
Capital/Financing Update Classification · 95% confidence The document is titled as a "重大资产购买暨关联交易报告书（草案）摘要" which translates to "Major Asset Purchase and Related Party Transaction Report (Draft) Summary." It details a major asset swap, issuance of shares, cash purchase of assets, and fundraising related to a significant restructuring transaction. The document includes detailed descriptions of the transaction parties, asset valuations, share issuance pricing, and regulatory approvals required. It references compliance with the China Securities Regulatory Commission (CSRC) and Shanghai Stock Exchange rules, and includes extensive financial and transaction details. This type of document is characteristic of a detailed transaction report related to a major asset restructuring and financing event, which aligns with the category of Capital/Financing Update (CAP). It is not a full annual or interim report, nor an earnings release or proxy statement. It is a comprehensive transaction disclosure report for a major asset purchase and related financing activities.
2020-09-17 Chinese
关于重大资产重组进展的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement regarding the progress of a major asset restructuring by Jiangxi Changjiu Biochemical Co., Ltd. It includes information about the asset swap, issuance of shares, cash payments, agreements signed, meetings held, inquiries from the Shanghai Stock Exchange, and ongoing updates on the restructuring process. The document is not a full financial report but rather a series of progress updates and disclosures related to a significant corporate transaction. It does not contain financial statements or comprehensive financial analysis but focuses on the status and procedural aspects of the major asset restructuring. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes, including major asset restructurings.
2020-09-17 Chinese
简式权益变动报告书（昌九集团、杭州昌信）
Major Shareholding Notification Classification · 95% confidence The document is titled as a "简式权益变动报告书" which translates to a "Simplified Equity Change Report." It details changes in shareholding percentages and share quantities of major shareholders in 江西昌九生物化工股份有限公司 (Jiangxi Changjiu Biochemical Co., Ltd.). The document includes detailed information about the shareholders, their shareholding before and after the transaction, the nature of the equity change (due to a major asset restructuring and capital raising), and legal compliance statements. It is not a full financial report, earnings release, or management discussion. It is a formal notification of changes in major shareholding stakes, consistent with the definition of a Major Shareholding Notification (MRQ). The document is substantive and not merely an announcement or a certification, so it is not classified as RNS or RPA. Therefore, the appropriate classification is MRQ with high confidence.
2020-09-17 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.